WASHINGTON (MedPage Today) -- An FDA advisory committee voted unanimously on Thursday to recommend approval of a new indication for ranibizumab (Lucentis) for the treatment of diabetic macular edema.
via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment